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Abstract  
Existing studies commonly rely on national official reports to estimate the impact of COVID-19 on human life. This 
is problematic because classification, estimation and reporting of COVID-19 mortality are not consistent across 
countries. To overcome these problems, this study exploits all cause daily death registrations data provided by 
the Italian Statistical Office (ISTAT) from January 1 to April 15, 2020. This allows us to: 1) calculate excess 
mortality in 2020 compared to the average of the years 2015 to 2019; and 2) estimate life expectancy on a 
seasonal and annual basis. Focusing on the five most severely hit provinces in Italy (Bergamo, Brescia, 
Cremona, Lodi and Piacenza) and Lombardy region, this analysis captures the impact of COVID-19 on mortality 
and life expectancy, which are likely to be underestimated when only national level data are considered. We find 
that seasonal life expectancy in 2020 in the five provinces reduced by 5.1 to 7.8 and 3.2 to 5.8 years for men and 
women, respectively. For annual life expectancy for the year 2020, in a scenario with no harvesting effect i.e. 
mortality rates resume to an average level of the years 2015-2019 after the end of the first epidemic wave, the 
years of life lost is equivalent to 2 to 3.5 years for men and 1.1. to 2.5 years for women in the five provinces. This 
represents the largest decline in life expectancy after the 1918 influenza pandemic and the Second World War. 
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Introduction 
 
Italy is the first country outside China and in Europe to experience the largest-scale impact of COVID-19 pandemic on 
human life. As the COVID-19 outbreak spread aggressively to other European countries, country disparities in COVID-
19 deaths became distinct. In particular, Italy, Belgium and the UK are shown to have the highest case fatality rates 
while Germany, Austria and Norway are among the European countries with the lowest rate (1). Comparing COVID-19 
deaths across countries, however, is challenging. Most of the existing literature has relied on case-fatality rates (CFR) 
as a measure of mortality (2–5), which are not informative for international and historical comparisons. Since case-
fatality rates are calculated as the number of deaths divided by the number of confirmed cases, the absence of 
accurate estimation of the infection rates in a reference population makes the denominator in the CFR reliant on testing 
strategies and capacities (6).  
Another issue with comparing COVID-19 deaths across countries is the absence of a uniform way in classifying, 
recording and reporting COVID-19 deaths (7). There is a variation across countries in counting mortality “from” and 
mortality “with” COVID-19. Italy, for instance, includes any persons who tested positive for the virus when they died in 
the official COVID-19 death toll statistics, regardless of the pre-existing diseases that may have caused death (5). 
Likewise, while countries like Belgium and France (after April 2) include coronavirus deaths outside hospitals in its 
official daily report, countries like the UK, Italy or Spain do not. Some countries such as Belgium, the UK and the US 
record COVID-19 deaths also from suspected cases and do not require a positive laboratory diagnosis unlike in 
Germany and the Netherlands (8). In addition, when the epidemic worsens, the counting of fatalities becomes more 
difficult. People dying at home or in long-term care facilities might indeed not be tested at all simply because resource 
allocation prioritizes emergency operations (9, 10). The overall number of COVID-19 deaths thus is most likely 
undercounted.  
The COVID-19 pandemic can also have an indirect impact on human life. As medical resources are primarily allocated 
for the treatment of COVID-19 patients, non-COVID medical emergencies and cares for chronic illness are likely to be 
undermined (11). Depleted hospital capacity in providing routine medical treatments coupled with reluctance to visit 
healthcare facilities due to a fear of the spread of COVID-19 infection within the hospital could contribute to peaks in 
mortality for other medical conditions that are not directly related to the epidemic (12). Arguably, these deaths should 
also be considered as death indirectly related to COVID-19.  
To overcome these problems, this study uses daily death registrations data for the period January 1 to April 15 2020 
published by the Italian Statistical Office (ISTAT). This allows us to calculate excess all-cause mortality during the 
period of the epidemic and corresponding annual life expectancy without suffering from selection bias related to 
sampling in testing and reporting policies. This is the first study to provide a complete assessment of the impact of 
COVID-19 on human life. 
In particular, this study focuses on specific geographical areas in Italy which are the most severely affected by the 
COVID-19 pandemic: four provinces in Lombardy (Bergamo, Lodi, Cremona, Brescia) and one province in Emilia 
Romagna (Piacenza). Indeed, Gatto et al. (13) in modelling the spread of COVID-19 in Italy highlight the importance of 
considering a spatial nature of the progress of the wave of infections. The selected provinces experienced the highest 
number of excess deaths in Italy in the period observed compared to the average level of mortality in the years 2015-
2019. The highly clustered nature of local transmission results in high concentration of severe illnesses and deaths in 
one area (14). Therefore, the direct impact of COVID-19 on mortality and average life expectancy is likely to be felt at a 
sub-national level rather than in a whole country. In fact, our results show that even in Lombardy – the hardest hit 
region (15) – the years of life lost due to COVID-19 appear to be significantly lower than in Bergamo, the province 
which contributed to one-third of the total excess mortality in the Lombardy region. A spatial granularity thus needs to 
be warranted in order to assess a full scale of human life impact. 
All rights reserved. No reuse allowed without permission. 
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 
The copyright holder for this preprintthis version posted May 13, 2020. .https://doi.org/10.1101/2020.04.29.20084335doi: medRxiv preprint 
  
3 
 
Based on daily death registrations data, the present study compares mortality rates in 2015-2019 and 2020 across age 
and gender categories and provides estimations of the changes in life expectancy following the COVID-19 pandemic. 
While measures such as mortality rates are no doubt useful, they need to be collapsed in an index which is universal 
enough to provide a reliable measure of human life lost. In this regard, life expectancy is significantly related to the 
overall wellbeing of population and could thus provide a simple, objective and immediate measure of the human 
casualties associated to unprecedented shocks such as the COVID-19 pandemic (16–18). Furthermore, reliable 
measures of life expectancy are available for some countries since the nineteenth century. This makes it possible to 
use life expectancy for historical comparisons of the human costs associated to major events 
Institutional and geographical context of the hardest hit areas 
In the early morning of February 21, 2020, the first severe case of local transmission was diagnosed in Europe, in a 
small hospital in Codogno, a municipality in the province of Lodi, southeast of Milan (19). Initially, authorities reacted by 
tracing the connections of patient one but finally failed to identify a patient zero. 11 municipalities within the province of 
Lodi were put under strict measures to contain the spread of the disease and declared the quarantine “Red Zone” as 
early as February 24, 2020. Meanwhile, another cluster of COVID-19 outbreak emerged in Alzano Lombardo and 
Nembro, two municipalities in the province of Bergamo, north east of Milan. Amidst the rapid rise in the number of 
detected cases, especially in the municipalities surrounding these two epicenters, on March 8 the Italian government 
imposed a (partial) nationwide lockdown from March 9, followed by a total lockdown of all non-essential activities on 
March 23, 2020 (20). Whilst the Italian government was praised by WHO for an implementation of such a drastic 
measure (not being employed in modern democratic nations since World War II), the virus has already spread 
undetected in the northern part of the country since late January 2020 (21–23). The containment measures thus might 
have been imposed a little too late (24). As a consequence, the outbreak has put unprecedented burden on the Italian 
healthcare system, resulting in an exceptionally high number of coronavirus deaths, currently the third highest in the 
world after the US and the UK (1). 
Geographically, Lodi and Codogno are close to other two provinces included in our sample, Cremona and Piacenza 
(see Fig. S1. and S2. in SI Appendix for a geographical location of the provinces being studied). The epidemic wave 
involving these provinces is thus considered as part of the Lodi-Codogno cluster. Bergamo and Brescia are located 
north-east of Milan and, despite the first COVID-19 severe cases being detected just one day after patient one in Lodi, 
experienced a week delay in the arrival of the epidemic wave (20). Lombardy, on the other hand, is the most populated 
region in Italy and the one with the highest Gross Domestic Product (GDP). Overall, it accounts for one sixth of the 
Italian population and one fifth of its GDP. Lombardy is relevant for our analysis because it is by far the hardest hit 
region by the COVID-19 pandemic in Italy, accounting for almost 50% of the human casualties of the entire country (6). 
Indeed, with the exception of Piacenza (locating in Emilia Romagna region), a bordering province with Lombardy 
region, all other four provinces included in the analysis are in Lombardy. In the following, we will thus also present 
statistics also for the region of Lombardy.  
Excess mortality  
The geographical distribution of excess deaths in the observed period across Italy (Fig. 1) matches with the distribution 
of confirmed cases (which comprise the deceased, recovered individuals and active cases) provided by the Italian Civil 
Protection Department, the official surveillance data on COVID-19 (25). This geographical pattern warrants that the 
excess mortality observed in our data represents mortality directly and indirectly related to COVID-19.  
Bergamo, Brescia, Cremona, Lodi and Piacenza represent the top five provinces in terms of increase in mortality in 
Italy.  The largest percentages increase in excess mortality is observed in Bergamo and Cremona. Clearly, Bergamo 
province shows the highest number of “red” areas – municipalities where excess mortality increased by over 300%. 
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When considering the number of deaths, the hardest hit provinces are also the most populated ones: Bergamo and 
Brescia.  
 
FIG. 1. ABOUT HERE 
 
Compared to the average number of people that died in the same period in the previous five years (2015-2019), the 
excess number of deaths (over 40) between January 1 and April 15, 2020 sums to 5686 in Bergamo, 3671 in Brescia, 
1756 in Cremona, 827 in Lodi and 906 in Piacenza. For the entire region of Lombardy the excess number of deaths 
are approximately 19,000 (See Table S1 in SI Appendix). Bergamo and Brescia have the highest number of excess 
deaths. In fact, the death toll in Bergamo alone accounts for almost one third of the excess mortality in Lombardy, 
underlining the clustering nature of the epidemic. Age clearly represents a risk factor for excess mortality in a similar 
manner as age-gradient in COVID-19 CFR found in Italy and elsewhere (26). For instance, among the excess deaths 
observed in Bergamo, mortality rate is much higher among older men aged 70 years and over (18 times higher than 
those aged below 70). A similar ratio is found in other provinces. 
When simply considering the distribution of excess mortality without adjusting for population size in each age-gender 
category, we observe slightly more excess mortality in men than in women (56% of excess deaths involve male 
subjects). This figure is not far from the death toll reported in official COVID-19 fatality data, where 63% of COVID-19 
deaths are males (27). However, when considering the mortality risk ratio between sexes, the excess mortality for 
males is consistently higher than that of females across all age groups and provinces. For example, between January 
1 and April 15, men 70-79 years old in Bergamo are 3.75 times more likely to die than women of the same age. It is 
evident that male sex is a risk factor associated with severe illness and deaths from COVID-19 in Italy (28) and 
elsewhere (29, 30). Our data on excess mortality represent similar sex disparities in COVID-19 related deaths. 
 
FIG. 2. ABOUT HERE 
 
Fig. 2 shows trends in daily mortality for the selected provinces and Lombardy. Plotting mortality distribution by age 
groups allows us to fully capture the progression of the epidemic in terms of mortality. It is evident how the epidemic 
curve inflates with age across all provinces. It is also clear that by April 15 the daily mortality in all selected provinces 
was approaching the pre-pandemic values. Hence, the wavelength of the epidemic in these provinces was between 6 
and 8 weeks, with the peak happening around two weeks after the onset of the outbreak. 
Vertical lines show four relevant dates for the evolution of the epidemic. With the case of patient one being first 
identified in Codogno located in the province of Lodi, the authorities quickly locked down 11 municipalities in the area 
on February 24, 2020. The containment measures through lockdown were only implemented in other provinces from 
March 8 on. Although the earlier lockdown enabled Lodi to flatten the curve more effectively than other severely hit 
provinces (Fig. 2), the province still experienced a notable increase in excess mortality. Considering that the incubation 
period – the time between exposure and symptom onset – can be up to 24 days (31, 32), it is evident that the lockdown 
were imposed too late in these provinces. Apart from political reasons preventing the authorities to introduce the 
lockdown earlier in the provinces where the number of cases had been risen rapidly like Bergamo, the recent evidence 
shows that COVID-19 has already been circulated undetected in northern Italy since January 2020 (21–23). Our study 
thus proxies the impact of COVID-19 outbreak in the absence of containment interventions.   
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Results 
In order to measure the human life impact of this epidemic on the selected five provinces and in Lombardy, we present 
estimated life expectancy for the year 2020 compared to that observed in the period 2015 to 2019 (Fig.3 and Fig.4). To 
obtain annual life expectancy, we need to predict mortality for the rest of the year. Here two scenarios are defined (see 
Materials and Methods for details about the approach). In the ‘conservative’ scenario, harvesting (i.e. the potential 
reduction in mortality rates following a temporary peak in mortality associated to negative shocks) is complete and the 
overall mortality rates by age at the end of the year are kept constant with respect to the previous five years. This 
approach implies by construction that everyone who died during COVID-19 would have died anyway during the year. In 
this setting, the main effect of COVID-19 is thus to anticipate mortality to the first quarter of the year 2020. Although 
this scenario is probably unlikely, it represents a clearly defined upper bound for life expectancy in 2020.  
In the ‘business as usual’ scenario, on the contrary, harvesting is set to zero and we assume that after the end of the 
epidemic, mortality rates will go back to the average levels recorded in the previous five years. There are good reasons 
to think that mortality will not reduce substantially after the end of the first wave of COVID-19 infections. For example, 
since most of the resources and health services have been directed to COVID-19 patients, people with other medical 
conditions such as cancer were under-treated. Likewise, although most vulnerable people have been doing self-
isolation and locking themselves inside, it is highly possible that they would get the virus later after restriction measures 
are lifted.  As a matter of fact, premature mortality after the first epidemic wave might actually increase as a 
consequence of the lockdowns and the following economic crises, as has been observed, for example, in Greece (33) 
and elsewhere in Europe after the 2008 global economic crisis (34, 35). Furthermore, in some provinces like Bergamo, 
the number of deaths of males in some age groups by April 15 has already exceeded the annual number of age-sex 
specific deaths in the same municipalities in 2017 (Fig. S3A and S3B in SI Appendix). Therefore, if anything, years of 
life lost due to COVID-19 for the year 2020 may in fact be underestimated. 
 
FIG. 3. ABOUT HERE 
 
When considering seasonal life expectancy, it is evident that life expectancy has reduced significantly for men and 
women in all provinces (Fig.3). When compared to the average life expectancy of the 2015-2019 period, the years of 
life lost for men range from 5.1 in Brescia to 7.8 in Bergamo and for women from 3.2 in Piacenza to the 5.8 in 
Bergamo. The higher years of life lost for men is due to sex differentials in COVID-19 mortality risk, as consistently 
found in both the official case fatality data (27, 36) and our death registration data. Indeed, when decomposing the loss 
in life expectancy to identify which age groups mainly contribute to a reduction in life expectancy (Fig. S4 in SI 
Appendix), it is clear that the older populations, especially men aged 60-79 years play a major role.  
 
FIG. 4. ABOUT HERE 
 
When life expectancy is extrapolated for the whole year (Fig.4), the loss in life expectancy is naturally diluted over a 
longer period. The drop in life expectancy due to COVID-19-related excess mortality thus is less sharp than that 
observed in seasonal life expectancy. In the conservative scenario of full harvesting (Fig. 4), not much changes are 
expected with respect to the previous years. This rather unlikely situation represents a potential upper bound of life 
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expectancy. Note however that in some cases life expectancy in 2020 drops even in this conservative scenario (for 
example, for men in Bergamo). This is because some age groups experienced already more deaths than in the past 
years. For these groups, the mortality for 2020 is thus likely to be higher than what experienced in the past, even if full 
harvesting is assumed (see Fig. S3A and S3B in SI Appendix).   
If mortality goes back to regular times (“business as usual” scenario) (Fig. 4), in the most severely hit province of 
Bergamo, life expectancy will drop by 3.55 and 2.48 years for men and women, respectively when compared to the 
years 2015-2017. In slightly less affected provinces of Brescia, Cremona, Lodi and Piacenza, the years of life lost for 
men are between 1.88 in Piacenza and 2.53 in Lodi and for women between 1.17 in Piacenza to 1.62 in Lodi. As 
expected, Lombardy shows a smaller reduction in life expectancy of 1.15. and 0.82 years for males and females, 
respectively.  
Discussion  
 
Avoiding the inconsistencies in classification of cause of deaths and in testing practices, this study estimates excess 
mortality directly and indirectly linked to COVID-19. By focusing on the five most severely affected areas in Italy and 
the most affected region of Lombardy, we are able to capture the full impact of COVID-19 on population health and 
human life.  
Two empirical regularities clearly emerge regarding demographic differentials. First, the age gradient in excess 
mortality is steep and age represents the most evident risk factor for COVID-19 mortality (26, 37). In Lombardy, men 
and women aged over 70 are 25 times and 66 times more likely to die than their counterparts aged under 70 and under 
60, respectively. These patterns are replicated in all five provinces. Therefore, an area with a high proportion of older 
populations (e.g. 17% of the population was over 70 in Lombardy region in 2019) would suffer a higher burden of 
COVID-19 mortality (38). Second, the risk of dying for men within each province is between 1.5 to 3.5 higher than that 
for women, depending on the age class and the province considered. Higher mortality rates consequently translate to a 
larger reduction in life expectancy for men than for women. 
In terms of life expectancy, we have shown two main set of results. First, when focusing on the period Jan 1 to April 15, 
2020, a reduction in seasonal life expectancy, compared with the average 2015-2019, can be as high as 7.8 years for 
men and 5.8 years for women in Bergamo, respectively. One way to interpret these figures is to consider mortality and 
corresponding life expectancy as seasonal (39).  
Moving forward, we can gauge how the COVID-19 pandemic would affect annual life expectancy for the year 2020. In 
the case of anticipated mortality caused by heat waves or cold spells, we typically observe harvesting effect where the 
frailest population subgroups die while strong individuals survive and later contribute to the number of deaths which are 
lower than expected  (40). In our case, although we do provide a scenario with harvesting effect in the calculation of 
annual life expectancy for the year 2020, this scenario is unlikely. In the five provinces considered, the no harvesting 
scenario implies a loss in life expectancy of around 2 to 3.5 years and 1.1 to 2.5 years for males and females, 
respectively. In fact, there remain many uncertainties regarding the longer-term effects of the pandemic on health 
conditions; for instance, regarding patients recovering from COVID-19 with important co-morbidities and mental health 
issues (41, 42) or pregnant women (43, 44). Indirect physical and mental health consequences following changing 
socioeconomic conditions might also affect mortality patterns in 2020 (45). Therefore, if anything, our estimates of 
annual life expectancy for 2020 in the business-as-usual scenario with no harvesting effect might represent a scenario 
which is not too pessimistic. 
The COVID-19 pandemic is often compared with the 1918 influenza pandemic (commonly known as “Spanish flu”) – 
the most severe pandemic in the last century. The COVID-19 pandemic brought about a large-scale loss in life 
expectancy from pandemics, second only to the 1918 Spanish flu, where life expectancy for Italy dropped by more than 
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15 years (See Fig. S5 in SI Appendix) and for the USA, by 11.8 years as estimated by Noymer and Garenne (46). 
Fortunately, the direct impact of COVID-19 on human life seems to be smaller than the 1918 Spanish flu for many 
reasons. First of all, since the Spanish flu typically killed younger people, it reduces life expectancy much more than 
the COVID-19 which is particularly fatal for older populations. Second, the outbreak of the Spanish flu occurred at the 
same time as the First World War when no public health and preventive measures were adequately implemented. The 
coexistence of war and pandemic made the Spanish flu exceptionally lethal. Finally, during the period of the 1918 
influenza pandemic, the medical knowledge and technology were much less advanced, with penicillin and other crucial 
pharmaceutical products not yet being available. It thus can be said that the years of life lost observed in the most 
severely affected areas of Italy, although not at the level achieved after the Spanish flu, are of a substantial scale given 
a much more advanced medical technology and the absence of war in the present day.  
The timing and the explicit focus on a local context can be considered as the strength of this analysis. Given that the 
COVID-19 outbreaks are geographically concentrated, looking at a country level life expectancy is misleading and 
underestimates the actual impact of the pandemic. The present analysis represents the first attempt to provide an 
evidence-based assessment of the human life impact from a frontline COVID-19 outbreak. In doing so, we raise a 
warning for the scientific and public health community around the world: the epidemic, when undetected and not 
contained, can easily get out of control and cause relevant social and human consequences. Vulnerable populations 
should be protected with a particular attention and constant monitoring of the epidemic progression. This should be 
given a priority in order not to get caught by surprise by devastating epidemic waves like the ones experienced in the 
most severely affected provinces in northern Italy 
At the same time, providing evidence right at the end of the first wave of COVID-19 epidemic in It comes at a price. that 
scenarios are needed regarding mortality for the remaining months of 2020. When it comes to annual life expectancy, 
we need to rely on harvesting assumptions and we exclude the possible negative impact of the present and future 
lockdown policies and global economic recessions on health and human life. Hence, this paper focuses on the direct 
impact of the first wave of the pandemic and, if anything, may underestimate the years of life lost due to the COVID-19.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
Human life in itself is a solid indicator of human development because it represents health and wellbeing of a 
population (16, 17), which is one key priority of the Sustainable Development Goals. So many years of life lost due to 
COVID-19 pandemic is worrisome since it sets the affected areas back to their level of human development 15 years 
ago. As shown in the cases of Bergamo, Brescia, Cremona, Lodi, and Piacenza, the cost of human life from a delay in 
public interventions to reduce the virus transmission is disturbingly high. Amidst countries’ preparation to ease the 
lockdown restrictions and social distancing measures, it is important to keep in mind the conceivable risk of viral 
reintroduction and a potential direct and indirect cost it can pose on human life. Well-planned government measures to 
prevent a second wave of infections along with public collaboration in keeping physical distancing and practicing 
proper hygiene until a vaccine for the novel coronavirus is available are key to achieve a balance between health and 
economic protection. 
  
All rights reserved. No reuse allowed without permission. 
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 
The copyright holder for this preprintthis version posted May 13, 2020. .https://doi.org/10.1101/2020.04.29.20084335doi: medRxiv preprint 
  
8 
 
Materials and Methods 
 
Estimate procedures for excess mortality 
 
We first estimate the resident population by age and sex for each of the selected five provinces on January 1, 2020 in 
the following steps. First, we aggregate resident population data by year, age class and sex at the province level. 
Then, we estimate the female and male resident population in each age class at the provincial level on January 1, 
2020 by means of linear extrapolation based on the years 2015 to 2019.  Likewise, we use available data on monthly 
live births between January 2015 and December 2019 to estimate monthly births over 2020 in each province. 
 
Excess mortality is measured at any time t in 2020 as the difference between the observed and the expected number 
of deaths in 2020 in t. The expected number of deaths in t is defined as the average number of deaths observed in t 
over the period 2015-2019: 
 .! 𝐷"	$"%$&&(𝑡'('() =	.! 𝐷"	)*&$+,$-(𝑡'('() −.! 𝐷"	$".$%/$-(𝑡'('() 
 
with .! 𝐷"	$".$%/$-(𝑡'('() = 1𝑘+.! 𝐷"0123 (𝑡'('(41) 
 
where the number of deaths in the age interval x to x+n at time t are defined as .! 𝐷"(𝑡). 
 
Estimate procedures for life expectancy 
(A) Seasonal life expectancy 
We calculate seasonal life expectancy for the period January 1 and April 15 for the years 2015-2020 (separated for 
men and women). To do so, seasonal age-specific mortality rates are calculated for each year. We aggregate the daily 
death counts (the numerators) over the period January 1 and April 15 at the provincial level (and at the regional level 
for Lombardy).  
The corresponding exposures (i.e., the denominators) were estimated as follows. Starting from the estimated resident 
population on January 1 in 2020, we counted age-specific person-days up to April 15. Theoretically, these counts are a 
function of four demographic events, namely births, ageing, migration, and dying. The daily inflow of births is estimated 
by using monthly birth data and assuming that these births are uniformly distributed throughout the month. The effect 
of ageing, i.e. individuals might be in transition in- and out of a given age interval, is modeled by giving each individual 
the probability of 1/365 for turning one year older during the observation period. The outflows due to deaths are 
straightforward as age-specific death counts are known on a daily basis. We assume no migration because the 
population being studied is under quarantine.  
Formally, the exposed population at day t in age group x is given by the population alive at day t-1 in age group x plus 
those who age into age group x at day t minus those who either die in age group x or age out of the age group x in day 
t: .! 𝐸"	. (𝑡) =.! 𝑃"(𝑡 − 1) +.! 𝐴𝑔𝑒_𝑖𝑛"(𝑡) −.! 𝐷"(𝑡) −.! 𝐴𝑔𝑒_𝑜𝑢𝑡"(𝑡) 
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We express the obtained daily exposure values in terms of person-years by multiplying them by 1/365 (1/366 for leap 
years). Then, we derive age-specific mortality rates for the period January 1 to April 15 by diving .! 𝐷"(𝑡) by .! 𝐸"(𝑡). 
Finally, life tables are built following standard procedures outlined by the Human Mortality Database protocol (47). Life 
expectancy at birth (seasonal or annual) can be expressed as: 
𝑒(. (𝑡) = 	 1𝑙(. 	+ 𝐿!. ". 	(𝑡)	6"2(  
with 𝐿!. ".  being the number of person-years lived between age x and x + n in a life table for the period t and 𝑙(.  the life 
table radix (i.e., 100,000 newborns).  
We estimate confidence intervals for life expectancies by bootstrapping using Monte Carlo simulation methods, 
assuming death counts follow a binomial distribution (48, 49).  
(B) Annual life expectancy 
When estimating life expectancy at the end of the year, harvesting (i.e. the reduction in mortality rates following peak 
mortality associated to shock events) should be taken into consideration (40). Here life expectancy for the entire 2020 
is estimated considering two alternative scenarios: 1) conservative scenario; and 2) business-as-usual scenario.   
In the conservative scenario (full harvesting), we assume the mortality rate at the end of the year will be the same as in 
2017. In this approach, the main effect of COVID-19 would be to anticipate mortality to the first quarter of the year 
2020. In the business-as-usual scenario, harvesting is set to zero and we assume that after the end of the epidemic, 
mortality rates will go back to the average levels recorded in the previous years.  
Based on the evolution of daily mortality observed until April 15, we posit that the epidemics in our area of interest 
should be over by April 30. To estimate life expectancy for the entire 2020, we need to project the evolution of deaths 
after April 15.  Cubic spline extrapolation is employed to project the number of daily deaths in each age class from April 
15 until April 30. After April 30, we project mortality until the end of the year based on the two scenarios.  
In the conservative scenario, we assume that after the end of the COVID-19 epidemics, deaths in each age class will 
occur such that the total number of deaths in 2020 equals the total number of deaths registered in 20171. If the 
cumulative number of deaths by the end of the epidemics in any age class exceeds the total number of deaths 
registered in 2017, we assume zero deaths will occur after the end of the epidemics in that age class.  
In the business-as-usual scenario, we assume that mortality will return to the average levels recorded in 2015-2017, 
the most recent years for which data on annual death counts are available. Thus, it is possible to derive the number of 
deaths occurring after April 30 as the difference between the annual death counts and deaths registered up to April 30 
for the years 2015-2017. As we do not know the daily distribution of deaths after April 30, we make two assumptions 
based on empirical evidence (39). For age groups <50, we assume that deaths occur uniformly over the period May 1 
–December 31, 2020. For age groups ≥50, we assume that deaths between May and December 2020 occur following 
the 2015-2019 average distribution of monthly deaths. We then assume that deaths distribute uniformly within each 
month between May and December 2020.  
 
1 2017 is the last year for which data on yearly death counts disaggregated by age and sex at the municipality level is 
available.  
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We then proceed with the estimation of population exposure for each day between January 1 and December 31, 2020 
under both scenarios following the same procedure detailed above. Finally, we aggregate death counts and population 
exposure values over the entire year to derive age-specific mortality rates and life expectancies under both scenarios.  
Data 
We rely on a compendium of administrative data provided by the Italian National Institute of Statistics (Istat). We use 
daily death counts for all causes at the municipality level, disaggregated by sex and five-year age class. They cover the 
period between January 1 and April 30 for the years 2015-2019, while for 2020 the observation period extends up to 
April 15. Importantly, Istat does not collect and release data on daily death counts for all Italian municipalities. These 
data are available for the 6,866 municipalities, out of a total of 7,904 municipalities in Italy, which have been included in 
the recently established National Register of Resident Population (ANPR). In our geographical areas of interest, the 
number of municipalities included in the ANPR ranges from 91% in the province of Piacenza to 99% in the province of 
Cremona. For Lombardy, the ANPR coverage is 96%. As of today, Istat has released daily death counts for all the 
municipalities included in the ANPR up to March 31, 2020. For a large subset of them (around 70% in our areas of 
interest), daily death counts are also available up to April 15, 2020. We summarize coverage of data on daily death 
counts in Table S2 in the Supplemental Material.  
In addition to this dataset, we rely on four further sources of information. First, we make use of annual death counts at 
the municipality level, disaggregated by sex and by five-year age group. These data extend up to 2017. Second, we 
obtain data on resident population at the municipality level, disaggregated by sex and single-year age classes on 
January 1 of for the years 2015-2019. We reclassify age classes to five-year age group so as to match the ones used 
by Istat for daily and annual death counts and aggregate data accordingly. Third, we use data on monthly live births, 
disaggregated by sex, at the municipality level. These data are available up to December 2019. Finally, we collect data 
on monthly death counts, disaggregated by sex, at the municipality level. These data are available up to December 
2019.  
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Figures and Tables 
 
 
 
 
Fig. 1. Excess mortality in Italy by municipality in (A) Bergamo, (B) Brescia, (C)  Cremona, (D) Lodi, (E) Piacenza and 
(F) Lombardy. The maps plot the percentages change in total number of deaths recorded between Jan 1 - Apr 15, 
2020 with respect to the 2015-2019 average.  
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Fig. 2. Trends in daily mortality by age in selected five provinces and in Lombardy: (A) Bergamo, (B) Brescia, (C)  
Cremona, (D) Lodi, (E)Piacenza and (F) Lombardy. The graphs plot the total daily death count between January 1 and 
April 15 (2020 vs 2015-2019 average), males and females combined. The vertical lines show relevant dates for the 
evolution of the epidemic. Vertical lines indicate relevant days: February 20 =Patient 1 found in Codogno; February 
23= Red zones in Codogno. Schools and Universities in affected Regions are closed; March 8= Lombardy and 
Piacenza 'orange zones; March 23= Closures of all non-essential economic activities. 
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Fig. 3. Estimates of seasonal (January 1- April 15) life expectancy at birth by sex in selected provinces and in 
Lombardy. Confidence intervals (95%) for life expectancies are estimated by bootstrapping using Monte Carlo 
simulation methods, assuming death counts follow a binomial distribution. 
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Fig.4. Estimates of annual life expectancy at birth by sex in selected provinces and in Lombardy (95% confidence 
intervals). Two scenarios: (A) conservative scenario; and (B) business as usual scenario. Confidence intervals (95%) 
for life expectancies are estimated by bootstrapping using Monte Carlo simulation methods, assuming death counts 
follow a binomial distribution 
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Supplementary text 
Methods 
 
Estimate of daily deaths up to April 15, 2020 
 
As specified in the Data section, daily death counts are available until April 15, 2020 for about 70% of municipalities in the 
geographical areas of interest. For the remaining 30%, daily death counts are available up to March 31, 2020. For 
municipalities in the latter subset, we extrapolate daily death counts until April 15, 2020 by assuming that daily deaths in 
each age class evolve at the same daily rate recorded by municipalities in the former subset between April 1 and April 15. 
Extrapolation is carried out at the provincial level.  
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Supplementary figures  
 
 
 
 
Fig. S1. Excess mortality distribution across Italian provinces. The provinces in Lombardy are highlighted by the bold 
black line. The province of Piacenza is indicated by the blue arrow.  
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Fig. S2. Excess mortality distribution in Municipalities in Lombardy. In bold, the borders of the provinces in Lombardy. The 
provinces of Bergamo, Brescia, Cremona and Lodi (included in the analysis) are highlighted.   
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All rights reserved. No reuse allowed without permission. 
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 
The copyright holder for this preprintthis version posted May 13, 2020. .https://doi.org/10.1101/2020.04.29.20084335doi: medRxiv preprint 
  
23 
 
 
 
 
Figure S3A: Cumulative number of deaths (January 1-April 15 2020) in the five provinces and in Lombardy for men. The 
red line represents the total number of death in 2017.  
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Figure S3B: Cumulative number of deaths (January 1- April 15 2020) in the five provinces and in Lombardy for men. The 
red line represents the total number of death in 2017.  
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Fig. S4. Decomposition of the seasonal loss of life expectancy, by age and sex and province. 
Note: For decomposing changes in life expectancy into age-specific contributions, the method proposed by Arriaga (1) is 
applied. This approach is used to assess which age-groups have primary contributed to the change in seasonal life 
expectancy between 2019 and 2020. 
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Fig. S5. Trends in life expectancies by countries since 1900.  
Note: Own elaborations from the Human Mortality Database.  
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Table. S1. Total population, excess mortality and male to female relative risk (RR)  by province, age and sex 
BERGAMO 
Age Population Males 
Population 
Females 
Excess 
deaths 
Males 
Excess 
deaths 
Females 
RR (M/F) 2020/(2015-19) Males 
2020/(2015-19) 
Female 
40-49 83509 88371 8 12 1.21 1.21 1.50 
50-59 84680 87182 104 32 2.02 2.20 1.53 
60-69 65702 63970 408 96 3.10 2.97 1.89 
70-79 53943 47212 1067 464 2.25 3.75 2.69 
80-89 34366 21564 1313 1013 1.79 3.23 2.48 
90+ 8521 2647 356 813 1.28 2.86 2.44 
BRESCIA 
Age Population Males 
Population 
Females 
Excess 
deaths 
Males 
Excess 
deaths 
Females 
RR (M/F) 2020/(2015-19) Males 
2020/(2015-19) 
Female 
40-49 96787 101696 6 2 1.99 1.14 1.10 
50-59 95941 97257 75 30 1.85 1.83 1.52 
60-69 74275 71060 203 62 2.54 1.91 1.54 
70-79 63616 55272 699 250 2.40 2.52 1.82 
80-89 41332 25220 808 662 1.69 2.18 1.84 
90+ 11317 3289 239 725 1.19 1.93 2.01 
CREMONA 
Age Population Males 
Population 
Females 
Excess 
deaths 
Males 
Excess 
deaths 
Females 
RR (M/F) 2020/(2015-19) Males 
2020/(2015-19) 
Female 
40-49 26859 27935 4 6 1.28 1.33 2.00 
50-59 27747 28265 31 1 2.48 2.15 1.05 
60-69 22991 22158 83 22 2.47 2.15 1.51 
70-79 19847 17233 298 110 2.43 2.80 2.00 
80-89 14157 8413 334 378 1.40 2.43 2.24 
90+ 3894 1198 147 342 1.29 2.58 2.29 
LODI 
Age Population Males 
Population 
Females 
Excess 
deaths 
Males 
Excess 
deaths 
Females 
RR (M/F) 2020/(2015-19) Males 
2020/(2015-19) 
Female 
40-49 17808 18599 4 0 2.30 1.50 1.00 
50-59 17423 18077 14 0 2.52 1.70 1.00 
60-69 13633 13116 65 23 2.40 2.59 2.00 
70-79 11515 9874 191 72 2.38 3.05 2.07 
80-89 7611 4446 173 118 1.85 2.34 1.73 
90+ 1838 549 36 131 1.08 1.78 2.07 
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PIACENZA 
Age Population Males 
Population 
Females 
Excess 
deaths 
Males 
Excess 
deaths 
Females 
RR (M/F) 2020/(2015-19) Males 
2020/(2015-19) 
Female 
40-49 20715 20861 4 -3 5.46 1.57 0.40 
50-59 21480 21466 22 6 2.35 1.88 1.43 
60-69 17056 16336 60 3 3.25 2.22 1.09 
70-79 15661 13350 157 70 2.23 2.21 1.86 
80-89 11442 7282 215 156 1.59 2.06 1.61 
90+ 3366 1144 65 151 1.21 1.71 1.66 
LOMBARDY 
Age Population Males 
Population 
Females 
Excess 
deaths 
Males 
Excess 
deaths 
Females 
RR (M/F) 2020/(2015-19) Males 
2020/(2015-19) 
Female 
40-49 761233 780876 35 10 1.74 1.11 1.05 
50-59 761806 756097 328 108 1.83 1.43 1.22 
60-69 595072 550240 1007 240 2.42 1.58 1.24 
70-79 525130 439579 3178 1269 2.14 1.85 1.49 
80-89 351948 219348 4471 3521 1.60 1.79 1.53 
90+ 90685 29070 1427 3437 1.21 1.68 1.60 
Legend 
Excess deaths: Number of deaths 1 January- 4 April 2020- Average number of death 1 January- 4 April (2015-2019) 
RR(M/F): Risk Ratio (Male/Female)=(excess death M/Pop M)/(excess death F/Pop F) 
2020/(2015-19): Number of deaths 1 January - 4 April 2020/Average number of death 1 January – 4 April (2015-2019) 
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Supplementary material: Data  
Table S2. Data coverage (number of municipalities) by province and for Lombardy 
 
 
Note: ANPR refers to the Anagrafe Nazionale della Popolazione Residente (National Register of Resident Population).   
  
# of 
municipalities
% of 
municipalities
% of 
population
# of 
municipalities
% of 
municipalities
% of 
population
Bergamo 243 237 237 97,5 98,4 171 70,4 77,7
Brescia 205 201 201 98,0 98,9 147 71,7 76,8
Cremona 113 112 112 99,1 99,8 79 69,9 76,2
Lodi 60 57 57 95,0 98,1 53 88,3 89,4
Piacenza 46 42 42 91,3 95,5 32 69,6 81,3
Lombardia 1505 1441 1441 95,8 97,1 1066 70,8 78,3
# of municipalities # of municipalities in the ANPR
Province / 
Region
Data until April 15 2020Data until March 31 2020
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